Semaphorin 3d signaling defects are associated with anomalous pulmonary venous connections

Nature Medicine

Volumn 19, Issue 6, 2013, Pages 760-765

  Degenhardt, Karl ^a   Singh, Manvendra K ^b   Aghajanian, Haig ^b   Massera, Daniele ^b   Wang, Qiaohong ^b   Li, Jun ^b   Li, Li ^b   Choi, Connie ^b   Yzaguirre, Amanda D ^b,c   Francey, Lauren J ^a   Gallant, Emily ^a   Krantz, Ian D ^a   Gruber, Peter J ^d   Epstein, Jonathan A ^b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTACTIC FACTOR; CHIMERIN; CRE RECOMBINASE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; NEUROPILIN 1; PHENYLALANINE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; SEMAPHORIN 3D; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOMEGALY; CHROMOSOME 4Q; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENDOTHELIUM CELL; GENETIC LINKAGE; HUMAN; HUMAN CELL; HUMAN CHROMOSOME; IMMUNOHISTOCHEMISTRY; LUNG VEIN DRAINAGE ANOMALY; MICRO-COMPUTED TOMOGRAPHY; MISSENSE MUTATION; MOUSE; NEURAL CREST; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PULMONARY VEIN; RETINA GANGLION CELL; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; ENDOTHELIAL CELLS; HUMANS; MICE; MICE, INBRED C57BL; MUTATION; NEOPLASM PROTEINS; NEUROPILIN-1; PULMONARY VEINS; SEMAPHORINS; SIGNAL TRANSDUCTION;

MUS;

EID: 84880319925     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3185     Document Type: Article

References (47)

1. Brody, H. Drainage of the pulmonary veins into the right side of the heart. Arch. Pathol. (Chic) 33, 221 (1942).
2. Lucas, R.V. Jr., Amplatz, K., Adams, P. Jr., Anderson, R.C. & Edwards, J.E. Congenital causes of pulmonary venous obstruction. J. Pediatr. 61, 281-282 (1962).
3. Lucas, R.V. Jr., Lock, J.E., Tandon, R. & Edwards, J.E. Gross and histologic anatomy of total anomalous pulmonary venous connections. Am. J. Cardiol. 62, 292-300 (1988).
4. Seale, A.N. et al. Total anomalous pulmonary venous connection: morphology and outcome from an international population-based study. Circulation 122, 2718-2726 (2010).
5. Adachi, B. Das Venensystem der Japaner 1st edn (Kenkyusha, Tokyo, 1933).
6. Healey, J.E. Jr. An anatomic survey of anomalous pulmonary veins: their clinical significance. J. Thorac. Surg. 23, 433-444 (1952).
7. Hughes, C.W. & Rumore, P.C. Anomalous pulmonary veins. Arch. Pathol. (Chic) 37, 364-366 (1944).
8. Kalke, B.R., Carlson, R.G., Ferlic, R.M., Sellers, R.D. & Lillehei, C.W. Partial anomalous pulmonary venous connections. Am. J. Cardiol. 20, 91-101 (1967).
9. Burroughs, J.T. & Edwards, J.E. Total anomalous pulmonary venous connection. Am. Heart J. 59, 913-931 (1960).
10. Auer, J. The development of the human pulmonary vein and its major variations. Anat. Rec. 101, 581-594 (1948).
11. Sizarov, A. et al. Three-dimensional and molecular analysis of the arterial pole of the developing human heart. J. Anat. 220, 336-349 (2012).
12. DeRuiter, M.C., Gittenberger-De Groot, A.C., Wenink, A.C., Poelmann, R.E. & Mentink, M.M. In normal development pulmonary veins are connected to the sinus venosus segment in the left atrium. Anat. Rec. 243, 84-92 (1995).
13. Douglas, Y.L., Jongbloed, M.R., Deruiter, M.C. & Gittenberger-de Groot, A.C. Normal and abnormal development of pulmonary veins: state of the art and correlation with clinical entities. Int. J. Cardiol. 147, 13-24 (2011).
14. Keane, J.F., Lock, J.E., Fyler, D.C. & Nadas, A.S. Nadas' Pediatric Cardiology (Saunders Elsevier, Philadelphia, 2006).
15. Moss, A.J. & Allen, H.D. Moss and Adams' Heart Disease in Infants, Children, and Adolescents: Including the Fetus and Young Adult (Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, 2008).
16. van den Berg, G. & Moorman, A.F. Development of the pulmonary vein and the systemic venous sinus: an interactive 3D overview. PLoS ONE 6, e22055 (2011).
17. Bleyl, S. et al. A gene for familial total anomalous pulmonary venous return maps to chromosome 4p13-q12. Am. J. Hum. Genet. 56, 408-415 (1995).
18. Bleyl, S.B. et al. Analysis of a Scottish founder effect narrows the TAPVR-1 gene interval to chromosome 4q12. Am. J. Med. Genet. A. 140, 2368-2373 (2006).
19. Bleyl, S.B. et al. Dysregulation of the PDGFRA gene causes inflow tract anomalies including TAPVR: integrating evidence from human genetics and model organisms. Hum. Mol. Genet. 19, 1286-1301 (2010).
20. Cinquetti, R. et al. Transcriptional deregulation and a missense mutation define ANKRD1 as a candidate gene for total anomalous pulmonary venous return. Hum. Mutat. 29, 468-474 (2008).
21. Kigel, B., Varshavsky, A., Kessler, O. & Neufeld, G. Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cells. PLoS ONE 3, e3287 (2008).
22. Kruger, R.P., Aurandt, J. & Guan, K.L. Semaphorins command cells to move. Nat. Rev. Mol. Cell Biol. 6, 789-800 (2005).
23. Larrivée, B., Freitas, C., Suchting, S., Brunet, I. & Eichmann, A. Guidance of vascular development: lessons from the nervous system. Circ. Res. 104, 428-441 (2009).
24. Gu, C. et al. Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins. Science 307, 265-268 (2005).
25. Feiner, L. et al. Targeted disruption of semaphorin 3C leads to persistent truncus arteriosus and aortic arch interruption. Development 128, 3061-3070 (2001).
26. Berndt, J.D. & Halloran, M.C. Semaphorin 3d promotes cell proliferation and neural crest cell development downstream of TCF in the zebrafish hindbrain. Development 133, 3983-3992 (2006).
27. Sato, M., Tsai, H.J. & Yost, H.J. Semaphorin3D regulates invasion of cardiac neural crest cells into the primary heart field. Dev. Biol. 298, 12-21 (2006).
28. Katz, T.C. et al. Distinct compartments of the proepicardial organ give rise to coronary vascular endothelial cells. Dev. Cell 22, 639-650 (2012).
29. Zhou, Y., Gunput, R.A. & Pasterkamp, R.J. Semaphorin signaling: progress made and promises ahead. Trends Biochem. Sci. 33, 161-170 (2008).
30. Herzog, Y., Guttmann-Raviv, N. & Neufeld, G. Segregation of arterial and venous markers in subpopulations of blood islands before vessel formation. Dev. Dyn. 232, 1047-1055 (2005).
31. Pellet-Many, C. et al. Neuropilin-1 mediates PDGF stimulation of vascular smooth muscle cell migration and signalling via p130Cas. Biochem. J. 435, 609-618 (2011).
32. Evans, I.M. et al. Neuropilin-1 signaling through p130Cas tyrosine phosphorylation is essential for growth factor-dependent migration of glioma and endothelial cells. Mol. Cell Biol. 31, 1174-1185 (2011).
33. Koppel, A.M., Feiner, L., Kobayashi, H. & Raper, J.A. A 70 amino acid region within the semaphorin domain activates specific cellular response of semaphorin family members. Neuron 19, 531-537 (1997).
34. Renzi, M.J., Feiner, L., Koppel, A.M. & Raper, J.A. A dominant negative receptor for specific secreted semaphorins is generated by deleting an extracellular domain from neuropilin-1. J. Neurosci. 19, 7870-7880 (1999).
35. Fu, W. et al. Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants. Nature 493, 216-220 (2013).
36. Jiang, Q. et al. Rapid and efficient human mutation detection using a bench-top next-generation DNA sequencer. Hum. Mutat. 33, 281-289 (2012).
37. Luzón-Toro, B. et al. Mutational spectrum of Semaphorin 3A and Semaphorin 3D genes in Spanish Hirschsprung patients. PLoS ONE 8, e54800 (2013).
38. Chauvet, S. et al. Gating of Sema3E/PlexinD1 signaling by neuropilin-1 switches axonal repulsion to attraction during brain development. Neuron 56, 807-822 (2007).
39. Riccomagno, M.M. et al. The RacGAP β2-chimaerin selectively mediates axonal pruning in the hippocampus. Cell 149, 1594-1606 (2012).
40. Silversides, C.K. et al. Rare copy number variations in adults with tetralogy of fallot implicate novel risk gene pathways. PLoS Genet. 8, e1002843 (2012).
41. Katz, T.C. et al. Distinct compartments of the proepicardial organ give rise to coronary vascular endothelial cells. Dev. Cell 22, 639-650 (2012).
42. Degenhardt, K., Wright, A.C., Horng, D., Padmanabhan, A. & Epstein, J.A. Rapid 3D phenotyping of cardiovascular development in mouse embryos by micro-CT with iodine staining. Circ. Cardiovasc. Imaging 3, 314-322 (2010).
43. Yokomizo, T. et al. Whole-mount three-dimensional imaging of internally localized immunostained cells within mouse embryos. Nat. Protoc. 7, 421-431 (2012).
44. Singh, M.K., Lu, M.M., Massera, D. & Epstein, J.A. MicroRNA-processing enzyme Dicer is required in epicardium for coronary vasculature development. J. Biol. Chem. 286, 41036-41045 (2011).
45. Merte, J. et al. A forward genetic screen in mice identifies Sema3A(K108N), which binds to neuropilin-1 but cannot signal. J. Neurosci. 30, 5767-5775 (2010).
46. Gitler, A.D., Lu, M.M. & Epstein, J.A. PlexinD1 and semaphorin signaling are required in endothelial cells for cardiovascular development. Dev. Cell 7, 107-116 (2004).
47. Gu, C. et al. Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins. Science 307, 265-268 (2005).